COMP <GO>
MSA vs MRK // EV/EBITDA & P/E VALUATION
MSA Safety Incorporated (NYSE) VS. Merck & Company Inc. Common Stock (new) (NYSE) • 15-METRIC TALLY: MSA 4
— MRK 10
▲ EV/EBITDA & P/E VALUATION LEADER: MRK
LAST: $178.57 (-0.33%) • MKT CAP: $6.91B
valuation
17.0x
LAST: $149.52 (+2.18%) • MKT CAP: $361.02B
valuation
15.3x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (MSA VS. MRK)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | MSA | MRK | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 46.50% | 74.80% | -28.30 | MRK | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 16.60% | 20.70% | -4.10 | MRK | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 17.0x | 15.3x | +1.70 | MRK | /valuation <GO> |
| Free Cash Flow Yield | 4.27% | 3.42% | +0.85 | MSA | /fcf-yield <GO> |
| Operating Margin | 19.80% | 34.30% | -14.50 | MRK | /operating-margins <GO> |
| Net Profit Margin | 14.90% | 28.10% | -13.20 | MRK | /net-margins <GO> |
| Revenue Growth (YoY) | 3.70% | 1.30% | +2.40 | MSA | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 1.19% | 2.26% | -1.07 | MRK | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 5.83 | 5.19 | +0.64 | MSA | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 7/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.50% | 6.60% | -0.10 | MSA | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 44.1 | 56.9 | -12.78 | MRK | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.87 | 0.92 | -0.05 | MRK | /macro-sensitivity <GO> |
| Forward P/E Multiple | 23.1x | 18.4x | +4.70 | MRK | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $6.91B | $361.02B | -$354.11B | MRK | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | MSA REV | MRK REV | MSA GROSS % | MRK GROSS % | MSA FCF | MRK FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.87B | $65.01B | 46.5% | 74.8% | $295.4M | $12.36B |
| FY 2024 | $1.81B | $64.17B | 47.6% | 76.3% | $242.2M | $18.10B |
| FY 2023 | $1.79B | $60.12B | 44.0% | 44.0% | $12.4M | $10.30B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
MSA // BETA 0.87
MRK // BETA 0.92